The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia.

Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease.

DNA hypo-methylating agents and sickle cell disease.

The mammalian amiloride-insensitive non-specific salt taste receptor is a vanilloid receptor-1 variant.

Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.

Basolateral Na+-H+ exchanger-1 in rat taste receptor cells is involved in neural adaptation to acidic stimuli.

Solvent-resistant photocurable liquid fluoropolymers for microfluidic device fabrication [corrected].

Na+-H+ exchange activity in taste receptor cells.

Self-assembly of phosphate fluorosurfactants in carbon dioxide.

Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease.